INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
KS

Kapadia Sandip

CHIEF FINANCIAL OFFICERCIK 0001677141

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 1
Max Insider Score21
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$139K
3,746 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Harmony Biosciences Holdings, Inc.CHIEF FINANCIAL OFFICER · Jan 26, 2026
9
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M
—
3,813 sh
Jan 24, 2026
Jan 26, 2026
traded Jan 24, 2026
+2d
SEC FORM 4

Evidence

9
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
4,725 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

12
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$94K
2,553 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

9
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
42.6K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

21
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
3,813 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

21
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
4,725 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

12
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$82K
2,239 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

9
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
12.2K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence